Lindsay Tribunal

WikiDoc Resources for Lindsay Tribunal
Articles
Most recent articles on Lindsay Tribunal Most cited articles on Lindsay Tribunal Review articles on Lindsay Tribunal Articles on Lindsay Tribunal in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Lindsay Tribunal Images of Lindsay Tribunal Photos of Lindsay Tribunal Podcasts & MP3s on Lindsay Tribunal Videos on Lindsay Tribunal
Evidence Based Medicine
Cochrane Collaboration on Lindsay Tribunal Bandolier on Lindsay Tribunal TRIP on Lindsay Tribunal
Clinical Trials
Ongoing Trials on Lindsay Tribunal at Clinical Trials.gov Trial results on Lindsay Tribunal Clinical Trials on Lindsay Tribunal at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Lindsay Tribunal NICE Guidance on Lindsay Tribunal NHS PRODIGY Guidance FDA on Lindsay Tribunal CDC on Lindsay Tribunal
Books
Books on Lindsay Tribunal
News
Lindsay Tribunal in the news Be alerted to news on Lindsay Tribunal News trends on Lindsay Tribunal
Commentary
Blogs on Lindsay Tribunal
Definitions
Definitions of Lindsay Tribunal
Patient Resources / Community
Patient resources on Lindsay Tribunal Discussion groups on Lindsay Tribunal Patient Handouts on Lindsay Tribunal Directions to Hospitals Treating Lindsay Tribunal Risk calculators and risk factors for Lindsay Tribunal
Healthcare Provider Resources
Symptoms of Lindsay Tribunal Causes & Risk Factors for Lindsay Tribunal Diagnostic studies for Lindsay Tribunal Treatment of Lindsay Tribunal
Continuing Medical Education (CME)
CME Programs on Lindsay Tribunal
International
Lindsay Tribunal en Espanol Lindsay Tribunal en Francais
Business
Lindsay Tribunal in the Marketplace Patents on Lindsay Tribunal
Experimental / Informatics
List of terms related to Lindsay Tribunal

The Lindsay Tribunal was set up in Ireland in 1999 to investigate the infection of haemophiliacs with HIV and Hepatitis C from contaminated blood products supplied by the Blood Transfusion Service Board.

There are about 400 haemophiliacs in Ireland. According to the tribunal a 'minimal figure' of 250 haemophilliacs were infected with HIV or Hepatitis C while receiving treatment from the BTSB before 1985.

Haemophilia is a genetic condition where the blood does not clot as quickly as normal due to a deficiency in certain proteins. This means they can suffer from internal bleeding - bruises and sprains can be much more serious for haemophiliacs.

Haemophiliacs may be treated by transfusions of the protein they are deficient in. One source of this protein is from human blood. Heat-treatment of blood products was started in the mid-eighties. Heat-treatment of blood products reduces the probability of infection from them. Since 1992 recombinant proteins are generally used, which contain little, if any, human blood products - and thus have a negligible risk of contamination.

Most of the blood products used by the BTSB were from local donations. However, some of it came from American suppliers which included blood from prisoners and drug addicts, who had a high risk of infection.

Findings

The Tribunal criticised the National Haemophilia Centre for its slow response to the risk of HIV infection. Findings of the Tribunal included:

• Patients were routinely started on home-treatment with possibly-dangerous commercial blood products, after the risk of infection had been discovered.
• Unheated blood products were probably not recalled after the safer heat-treated products became available.
• There was no formal means for communicating with regional centres to stop using unheated blood-products.
• There was an unacceptable delay between testing for HIV and Hepatitis and notification of the results (up to 4 years)

Links:

Irish Haemophilia Society Website

Article on the Tribunal

Template:WikiDoc Sources